---
document_datetime: 2024-08-07 12:50:49
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/adzynma-epar-all-authorised-presentations_en.pdf
document_name: adzynma-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.7755473
conversion_datetime: 2025-12-23 08:14:42.079536
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical Form                           | Route of Administration   | Immediate Packaging                         | Content (concentration)                    | Pack size                                                                                               |
|------------------|-------------------|------------|-----------------------------------------------|---------------------------|---------------------------------------------|--------------------------------------------|---------------------------------------------------------------------------------------------------------|
| EU/1/24/1837/001 | ADZYNMA           | 500 IU     | Powder and solvent for solution for injection | Intravenous use           | powder: vial (glass); solvent: vial (glass) | powder: 500 IU; solvent: 5 ml (100 IU/ml)  | 1 powder vial + 1 solvent vial + 1 reconstitution device + 1 syringe + 1 infusion set + 2               |
| EU/1/24/1837/002 | ADZYNMA           | 1500 IU    | Powder and solvent for solution for injection | Intravenous use           | powder: vial (glass); solvent: vial (glass) | powder: 1500 IU; solvent: 5 ml (300 IU/ml) | 1 powder vial + 1 solvent vial + 1 reconstitution device + 1 syringe + 1 infusion set + 2 alcohol swabs |